Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer
NCT07009600
·
clinicaltrials.gov ↗
COMPLETED
Status
124
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer Stage IV
Interventions
DRUG:
immune check point inhibitors (PD-1 inhibitors), target therapy (trastuzumab)
Sponsor
Samsung Medical Center